Aarzoo Thakur

university of washington

H指数:8

被引数:285

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of Late Second to Early Third Trimester of Pregnancy on the Activity of Renal Organic Anion Transporters (OAT1 and OAT3): A Biomarker Study

妊娠晚期至第三孕早期对肾有机阴离子转运蛋白（OAT1和OAT3）活性的影响：一项生物标志物研究

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2026-05-110

OAAI

From Discovery to Translation: Endogenous Substrates of OAT1 and OAT3 as Clinical Biomarkers for Renal Secretory Function

从发现到转化：OAT1和OAT3的内源性底物作为肾分泌功能的临床生物标志物

Clinical Pharmacology & Therapeutics

IF5.5

2025-05-220

PRE

Quantitative Contributions of Hepatic and Renal Organic Cation Transporters to the Clinical Pharmacokinetic Cimetidine-Metformin Interaction

肝和肾有机阳离子转运体对临床药代动力学西咪替丁-二甲双胍相互作用的定量贡献

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2025-03-170

Confounding Effect of Phenol Red on OAT-and OATP-Mediated Transporter Assays: Implications for Accuracy and Translatability of In Vitro Data

酚红对OAT和OATP介导转运体测定的混淆效应：对体外数据准确性和可转化性的影响

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2025-03-010

PRE

Identification of Potential Endogenous Substrates of Cytochrome P450 Enzymes Using an Optimized Metabolomics-Based Approach

利用优化的基于代谢组学的方法鉴定细胞色素P450酶的潜在内源性底物

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2025-03-010

PRE

Pyridoxic Acid as Endogenous Biomarker of Renal Organic Anion Transporter Activity: Population Variability and Mechanistic Modeling to Predict Drug-Drug Interactions

吡啶酸作为肾有机阴离子转运蛋白活性的内源性生物标志物: 预测药物-药物相互作用的群体变异性和机制模型

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2025-02-240

Developmental Expression of Drug Transporters and Conjugating Enzymes Involved in Enterohepatic Recycling: Implication for Pediatric Drug Dosing

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2024-08-190

PRE

Age-Dependent Abundance of CYP450 Enzymes Involved in Metronidazole Metabolism: Application to Pediatric PBPK Modeling

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2024-07-021

PRE

Sex and the Kidney Drug-Metabolizing Enzymes and Transporters: Are Preclinical Drug Disposition Data Translatable to Humans?

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2024-05-063

PRE

Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers

BIOCHEMICAL PHARMACOLOGY

IF5.6

2023-12-018

PRE

Identification of endogenous biomarkers of renal organic cation transporters in rats by global metabolomics analysis

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2023-06-010

OAAI

High-Resolution Mass Spectrometry Coupled with XCMS Online for High-throughput Detection and Identification of Drug Metabolites

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2023-06-010

OAAI

Identification of Putative Novel Biomarkers of Organic Anion Transporter 1 and 3 for the Prediction of Transporter-Mediated Drug-Drug Interactions

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2023-06-010

OAAI

Assessing the Effect of Organic Anion Transporter Inhibition on Circulating Pyridoxic Acid, an Endogenous Transporter Biomarker, using Physiologically-based Pharmacokinetic Modeling

FASEB JOURNAL

IF4.2

2022-05-130

PRE

Bioanalytical strategies in drug discovery and development

DRUG METABOLISM REVIEWS

IF3.8

2021-08-2310

PREAI

Contribution of Uptake and Efflux Transporters to Oral Pharmacokinetics of Furosemide

ACS OMEGA

IF4.3

2020-12-1519

OAAI

Physiologically-Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS-CoV-2

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2020-10-066

OAAI

A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation

SCIENTIFIC REPORTS

IF3.9

2019-07-0444

OAAI

Aarzoo Thakur

个人简介

教育背景

工作经历

荣誉奖项

研究方向